As demonstrated in this study, all tested tumor samples expressed MLH1, MSH2, MSH6 and PMS2 in normal and tumor cells to a high level (both, score and intensity), and there was no correlation with any patient characteristics. This evidence concerns the gene MSH2 and neoplasm.